rs6755901

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000233.4(LHCGR):​c.866+8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.819 in 1,612,146 control chromosomes in the GnomAD database, including 546,775 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.81 ( 50083 hom., cov: 32)
Exomes 𝑓: 0.82 ( 496692 hom. )

Consequence

LHCGR
NM_000233.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00006589
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.574

Publications

14 publications found
Variant links:
Genes affected
LHCGR (HGNC:6585): (luteinizing hormone/choriogonadotropin receptor) This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]
GTF2A1L (HGNC:30727): (general transcription factor IIA subunit 1 like) The assembly and stability of the RNA polymerase II transcription pre-initiation complex on a eukaryotic core promoter involve the effects of transcription factor IIA (TFIIA) on the interaction between TATA-binding protein (TBP) and DNA. This gene encodes a germ cell-specific counterpart of the large (alpha/beta) subunit of general transcription factor TFIIA that is able to stabilize the binding of TBP to DNA and may be uniquely important to testis biology. Alternative splicing for this locus has been observed and two variants, encoding distinct isoforms, have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (SALF), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 2-48698607-C-T is Benign according to our data. Variant chr2-48698607-C-T is described in ClinVar as [Benign]. Clinvar id is 255608.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.855 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LHCGRNM_000233.4 linkc.866+8G>A splice_region_variant, intron_variant Intron 9 of 10 ENST00000294954.12 NP_000224.2 P22888-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LHCGRENST00000294954.12 linkc.866+8G>A splice_region_variant, intron_variant Intron 9 of 10 1 NM_000233.4 ENSP00000294954.6 P22888-1
ENSG00000279956ENST00000602369.3 linkn.*139+8G>A splice_region_variant, intron_variant Intron 8 of 12 5 ENSP00000473498.1 R4GN57

Frequencies

GnomAD3 genomes
AF:
0.806
AC:
122490
AN:
152000
Hom.:
50033
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.862
Gnomad AMI
AF:
0.891
Gnomad AMR
AF:
0.690
Gnomad ASJ
AF:
0.849
Gnomad EAS
AF:
0.477
Gnomad SAS
AF:
0.796
Gnomad FIN
AF:
0.692
Gnomad MID
AF:
0.785
Gnomad NFE
AF:
0.838
Gnomad OTH
AF:
0.811
GnomAD2 exomes
AF:
0.752
AC:
188938
AN:
251182
AF XY:
0.764
show subpopulations
Gnomad AFR exome
AF:
0.864
Gnomad AMR exome
AF:
0.537
Gnomad ASJ exome
AF:
0.838
Gnomad EAS exome
AF:
0.471
Gnomad FIN exome
AF:
0.696
Gnomad NFE exome
AF:
0.836
Gnomad OTH exome
AF:
0.783
GnomAD4 exome
AF:
0.820
AC:
1197202
AN:
1460028
Hom.:
496692
Cov.:
35
AF XY:
0.820
AC XY:
595777
AN XY:
726472
show subpopulations
African (AFR)
AF:
0.865
AC:
28908
AN:
33438
American (AMR)
AF:
0.559
AC:
24994
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.843
AC:
22021
AN:
26126
East Asian (EAS)
AF:
0.481
AC:
19103
AN:
39690
South Asian (SAS)
AF:
0.799
AC:
68935
AN:
86230
European-Finnish (FIN)
AF:
0.699
AC:
37152
AN:
53186
Middle Eastern (MID)
AF:
0.781
AC:
4475
AN:
5732
European-Non Finnish (NFE)
AF:
0.849
AC:
942815
AN:
1110576
Other (OTH)
AF:
0.809
AC:
48799
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
9692
19385
29077
38770
48462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21022
42044
63066
84088
105110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.806
AC:
122595
AN:
152118
Hom.:
50083
Cov.:
32
AF XY:
0.795
AC XY:
59102
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.862
AC:
35792
AN:
41514
American (AMR)
AF:
0.689
AC:
10542
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.849
AC:
2947
AN:
3472
East Asian (EAS)
AF:
0.476
AC:
2451
AN:
5144
South Asian (SAS)
AF:
0.797
AC:
3847
AN:
4824
European-Finnish (FIN)
AF:
0.692
AC:
7314
AN:
10568
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.838
AC:
56949
AN:
67992
Other (OTH)
AF:
0.813
AC:
1716
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1173
2346
3518
4691
5864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.828
Hom.:
99239
Bravo
AF:
0.803
Asia WGS
AF:
0.702
AC:
2443
AN:
3478
EpiCase
AF:
0.844
EpiControl
AF:
0.843

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 26, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypergonadotropic hypogonadism Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leydig cell agenesis Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Gonadotropin-independent familial sexual precocity Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
7.3
DANN
Benign
0.78
PhyloP100
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000066
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6755901; hg19: chr2-48925746; COSMIC: COSV54292706; API